Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

97bdef63-6ade-44f8-ba4e-f6b5b344f17a - samples

ABSTRACT: Enhanced reduced representation bisulfite sequencing (eRRBS) on 45 multiple myeloma samples and 3 normal plasma cell. Enhanced reduced representation bisulfite sequencing (eRRBS) on 45 multiple myeloma samples and 3 normal plasma cell. Libraries were sequenced on a HiSeqTM4000 Illumina machine using 75bp paired-end reads

PROVIDER: EGAD00001007822 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Enhanced reduced representation bisulfite sequencing (eRRBS) on 45 multiple myeloma samples and 3 normal plasma cell

Project description:Enhanced reduced representation bisulfite sequencing (eRRBS) on 45 multiple myeloma samples and 3 normal plasma cell. Libraries were sequenced on a HiSeqTM4000 Illumina machine using 75bp paired-end reads

| EGAS00001004348 | EGA

Mus musculus

Project description:Reduced representation bisulfite sequencing

| PRJNA347548 | ENA

Enhanced Reduced Representation Bisulfite Sequencing of BPH and control samples

Project description:Enhanced Reduced Representation Bisulfite Sequencing of BPH and control samples

| PRJNA507569 | ENA

Project description:Tree swallow reduced representation bisulfite sequencing

| PRJNA953597 | ENA

Project description:H358 cells reduced representation bisulfite sequencing

| PRJNA578952 | ENA

Tet2 deletion mediated DNA methylation changes in the mouse mammary gland

Project description:We used enhanced reduced representation bisulfite sequencing (ERRBS) analysis to dertemine global DNA methylation perturbed by loss of TET2 in the mouse mammary gland.

2020-07-16 | GSE147367 | GEO

Whole Genome Sequencing to Discover Familial Myeloma Risk Genes

Project description:<p>We identified germline <a href="https://www.ncbi.nlm.nih.gov/gene/?term=23028">KDM1A</a> truncating mutations in patients with multiple myeloma (MM), and loss of heterozygosity (LOH) in tumors. KDM1A mutation burden is higher in sporadic MM patients than in controls, and mRNA levels are lower in MM compared with normal plasma cells. KDM1A pharmacological inhibition in vitro promotes myeloma cell proliferation, and in mice promotes plasma cell expansion, enhanced secondary immune response to T cell dependent antigens, and upregulation of MYC oncogene transcriptional targets. Our findings provide important new insights into the role of KDM1A to suppress B cell malignancies.</p>

| phs001819 | dbGaP

Reduced representation bisulfite sequencing of equine tissue

Project description:Reduced representation bisulfite sequencing of equine tissue

| PRJNA789530 | ENA

Project description:reduced representation bisulfite sequencing on N2a cells

| PRJNA593386 | ENA

Homo sapiens

Project description:RRBS (Reduced Representation Bisulfite Sequencing) of HL60

| PRJNA154871 | ENA